CN101784561A - 用于诊断或筛选节肢介体病毒感染的方法、在所述方法和它们的应用中使用的试剂 - Google Patents

用于诊断或筛选节肢介体病毒感染的方法、在所述方法和它们的应用中使用的试剂 Download PDF

Info

Publication number
CN101784561A
CN101784561A CN200880103542A CN200880103542A CN101784561A CN 101784561 A CN101784561 A CN 101784561A CN 200880103542 A CN200880103542 A CN 200880103542A CN 200880103542 A CN200880103542 A CN 200880103542A CN 101784561 A CN101784561 A CN 101784561A
Authority
CN
China
Prior art keywords
ala
gly
thr
leu
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200880103542A
Other languages
English (en)
Chinese (zh)
Inventor
于格·贝杜埃勒
埃洛蒂·布里安-利茨勒
菲利普·迪萨尔
菲利普·德普雷斯
利蒂希娅·布勒芒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut Pasteur
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut Pasteur filed Critical Centre National de la Recherche Scientifique CNRS
Publication of CN101784561A publication Critical patent/CN101784561A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
    • G01N2333/185—Flaviviruses or Group B arboviruses, e.g. yellow fever virus, japanese encephalitis, tick-borne encephalitis, dengue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CN200880103542A 2007-06-15 2008-06-13 用于诊断或筛选节肢介体病毒感染的方法、在所述方法和它们的应用中使用的试剂 Pending CN101784561A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07290749A EP2003144A1 (en) 2007-06-15 2007-06-15 Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications
EP07290749.6 2007-06-15
PCT/IB2008/002614 WO2008152528A2 (en) 2007-06-15 2008-06-13 Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications

Publications (1)

Publication Number Publication Date
CN101784561A true CN101784561A (zh) 2010-07-21

Family

ID=38740531

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880103542A Pending CN101784561A (zh) 2007-06-15 2008-06-13 用于诊断或筛选节肢介体病毒感染的方法、在所述方法和它们的应用中使用的试剂

Country Status (8)

Country Link
US (1) US8357496B2 (enExample)
EP (2) EP2003144A1 (enExample)
JP (1) JP2010530960A (enExample)
CN (1) CN101784561A (enExample)
AU (1) AU2008263507B2 (enExample)
BR (1) BRPI0814247A2 (enExample)
CA (1) CA2690764A1 (enExample)
WO (1) WO2008152528A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108486219A (zh) * 2018-03-28 2018-09-04 中国人民解放军军事科学院军事医学研究院 一种检测离体血清样本是否感染乙型脑炎病毒的试剂盒
CN110996996A (zh) * 2017-03-15 2020-04-10 金·安德列·布洛姆尼伦 疫苗

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2272860A1 (en) * 2009-07-10 2011-01-12 Institut Pasteur Multivalent epitope in complex with a detection marker for the early serodiagnosis of infections
US8999675B2 (en) 2009-08-31 2015-04-07 Gen-Probe Incorporated Dengue virus assay
JP2015535841A (ja) * 2012-09-27 2015-12-17 アイデックス ラボラトリーズ インコーポレイテッドＩＤＥＸＸ Ｌａｂｏｒａｔｏｒｉｅｓ， Ｉｎｃ． シュマーレンベルグウイルス（ｓｂｖ）の検出方法及びキット
JP5866715B2 (ja) 2013-10-18 2016-02-17 国立大学法人九州大学 タンパク質検出用融合タンパク質およびタンパク質の検出方法
BR112018074620A2 (pt) 2016-06-06 2019-03-06 Medizinische Universität Wien método para a detecção de um anticorpo de igm específico para um flavivírus em uma amostra
US20190358313A1 (en) * 2016-12-23 2019-11-28 Expres2Ion Biotechnologies Aps New flavivirus vaccine
JP7572780B2 (ja) * 2017-04-26 2024-10-24 エフ． ホフマン－ラ ロシュ アーゲー 可溶性および免疫反応性のジカウイルスｎｓ１ポリペプチド

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2157767A1 (en) * 1993-03-09 1994-09-15 Elaine M. Brate Genetically engineered enzymes and their conjugates for diagnostic assays
FR2736065B1 (fr) * 1995-06-29 1997-09-19 Commissariat Energie Atomique Phosphatases alcalines bacteriennes modifiees et leurs applications.
US7227011B2 (en) * 1998-06-04 2007-06-05 United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Nucleic acid vaccines for prevention of flavivirus infection
US7785799B2 (en) * 2002-08-16 2010-08-31 The Board Of Regents Of The University Of Texas System Compositions and methods related to flavivirus envelope protein domain III antigens
DE602005025647D1 (de) * 2004-07-23 2011-02-10 Novartis Vaccines & Diagnostic Polypeptide für die oligomerisierung von antigenen

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CECILE D MARTIN ET AL: "A simple vector system to improve performance and utilisation of recombinant antibodies", 《BMC BIOTECHNOLOGY》 *
CHRISTOPHER W. ROBB ET AL: "Expression of an 18 kDa PhoA fusion protein in Mycobacterium spp", 《JOURNAL OF MICROBIOLOGICAL METHODS》 *
RICHARD M. WRIGHT ET AL: "A high-capacity alkaline phosphatase reporter system for the rapid analysis of specificity and relative affinity of peptides from phage-display libraries", 《JOURNAL OF IMMUNOLOGICAL METHODS》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110996996A (zh) * 2017-03-15 2020-04-10 金·安德列·布洛姆尼伦 疫苗
CN108486219A (zh) * 2018-03-28 2018-09-04 中国人民解放军军事科学院军事医学研究院 一种检测离体血清样本是否感染乙型脑炎病毒的试剂盒
CN108486219B (zh) * 2018-03-28 2022-02-25 中国人民解放军军事科学院军事医学研究院 一种检测离体血清样本是否感染乙型脑炎病毒的试剂盒

Also Published As

Publication number Publication date
CA2690764A1 (en) 2008-12-18
EP2170936A2 (en) 2010-04-07
EP2003144A1 (en) 2008-12-17
US20100291586A1 (en) 2010-11-18
BRPI0814247A2 (pt) 2015-01-06
AU2008263507A1 (en) 2008-12-18
JP2010530960A (ja) 2010-09-16
WO2008152528A2 (en) 2008-12-18
WO2008152528A3 (en) 2009-03-12
AU2008263507B2 (en) 2013-09-12
US8357496B2 (en) 2013-01-22

Similar Documents

Publication Publication Date Title
CN101784561A (zh) 用于诊断或筛选节肢介体病毒感染的方法、在所述方法和它们的应用中使用的试剂
US7947494B2 (en) Fusion protein comprising an E. coli chaperone protein and a human chaperone protein
CA2645194C (en) Isolation of binding proteins with high affinity to ligands
CN103751773B (zh) 稳定表达猪瘟病毒e0-e1-e2蛋白的重组bhk细胞系及其在制备猪瘟疫苗与诊断试剂中的应用
AnandaRao et al. A custom-designed recombinant multiepitope protein as a dengue diagnostic reagent
CA2501188C (en) Combinatorial protein library screening by periplasmic expression
JPH05507612A (ja) Ｃ型肝炎ウイルスプロテアーゼ
Gaspar-Castillo et al. Structural and immunological basis of cross-reactivity between dengue and Zika infections: Implications in serosurveillance in endemic regions
US20060029947A1 (en) Combinatorial protein library screening by periplasmic expression
CN112724208A (zh) 一种SADS-CoV重组S蛋白胞外段及其制备方法与应用
CN107190013A (zh) 一种以人Ad5复制缺陷型腺病毒为载体的寨卡病毒病疫苗
JP6285934B2 (ja) イムノアッセイの干渉の低減、及び安定化のためのシャペロン−シャペロン融合ポリペプチド
JP2022536960A (ja) Ｌｉｓｔｅｒｉａの検出のための変異体バクテリオファージを生成するための方法
EP1780282B1 (en) Recombinant expression of Rubella E1 envelope protein variants as chaperone fusion-proteins, and their use in the detection of anti-Rubella antibodies
CA2562738C (en) Soluble rubella e1 envelope antigens
KR101672446B1 (ko) 바실러스 세레우스 세포벽 결합 폴리펩타이드 및 바실러스 세레우스 검출용 매개체
CN115948439A (zh) 噬菌体辅助内含肽进化系统及进化方法
IE911130A1 (en) Hepatitis c protease inhibitors
EP0600018B1 (en) Hepatitis c assay utilizing recombinant antigens to c-100 region
Royuela et al. Molecular cloning, expression and first antigenic characterization of human astrovirus VP26 structural protein and a C-terminal deleted form
RU2073718C1 (ru) Фрагмент днк нс 280, полученный с помощью химического синтеза, рекомбинантный полипептид нс 280 молекулярной массы 120-130 кда, обладающий способностью связывать антитела к продукту гена белка ns4 вируса гепатита с, полученный при культивировании штамма бактерий escherichia coli - штамм бактерий escherichia coli - продуцент рекомбинантного полипептида нс 280, обладающего способностью связывать антитела к продукту гена белка ns4 вируса гепатита с
Saxena et al. Heterologous expression of envelope Protein (Domain III) of Dengue Virus Type 2 for Serodiagnosis
RU2565545C1 (ru) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pFLAG-sc14D5a-Rm7, ОБЕСПЕЧИВАЮЩАЯ СИНТЕЗ ГИБРИДНОГО БЕЛКА sc14D5a-Rm7, ШТАММ БАКТЕРИЙ Escherichia coli - ПРОДУЦЕНТ ГИБРИДНОГО БЕЛКА sc14D5a-Rm7 И ГИБРИДНЫЙ БЕЛОК sc14D5a-Rm7, СВЯЗЫВАЮЩИЙ БЕЛОК Е ВИРУСА КЛЕЩЕВОГО ЭНЦЕФАЛИТА И ОБЛАДАЮЩИЙ БИОЛЮМИНЕСЦЕНТНОЙ АКТИВНОСТЬЮ
Andrew et al. Malaysian Journal of Microbiology
Lei et al. Impaired heterologous protein-protein interaction is an essential cause for non-viability of WNV/DENV recombinants

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20100721